Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Driving Performance Evaluation of TS-142 in Healthy Non-elderly and Elderly Adults
jRCT2071200075Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of vornorexant in Insomnia (2 arms), sponsored by Taisho Pharmaceutical. Primary endpoint: Standard Deviation of Lateral Position (SDLP). Started Jan 2021; status: completed.
02
Drugs
vornorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2071200075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200075.